Herantis Pharma: Our H1 Comment - Redeye
Bildkälla: Stockfoto

Herantis Pharma: Our H1 Comment - Redeye

Redeye comments on yesterday’s H1 report from Herantis and we reiterate our view of the company.

Börsvärldens nyhetsbrev